6533b870fe1ef96bd12cf3b3

RESEARCH PRODUCT

Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis

Daniele Roberto GiacobbeErika AspergesAndrea CortegianiCecilia GrecchiChiara RebuffiValentina ZuccaroLuigia Scudeller Bassetti Matteo Fundicu Investigators: Murat AkovaAlastruey-izquierdo AnaArikan-akdagli SevtapAzoulay ElieI Blot StijnA Cornely OliverLass-flörl CorneliaKoehler PhilippCuenca-estrella ManuelW De Lange DylanG De Rosa FrancescoJ De Waele JanDimopoulos GeorgeGarnacho-montero JoséHoenigl MartinS Kanj SouhaLamoth FredericMaertens JohanMartin-loeches IgnacioMuñoz PatriciaJ Kullberg BartAgvald-ohman ChristinaPoulakou GaryphalliaRello JordiSanguinetti MaurizioS Taccone FabioTimsit Jean-françoisTorres AntoniA Vazquez JoseWauters JoostCalandra ThierryTejada SofiaKaraiskos IliasMaddalena PeghinVena AntonioL Mortensen KlausLebihan Clement Toine Mercier Affiliations

subject

AdultAntifungal AgentsCritical CarediagnosisCritical IllnesscandidemiaDermatologyGeneral Medicineinvasive candidiasisIC.Intensive Care UnitsInfectious DiseasesCandida; biomarker; candidaemia; deep-seated candidiasis; diagnosis; invasive candidiasisHumansbiomarkercandidaemiaCandidiasis InvasiveProspective Studiesdeep-seated candidiasisCandida

description

Background The Fungal Infections Definitions in Intensive Care Unit (ICU) patients (FUNDICU) project aims to provide standard sets of definitions for invasive fungal diseases in critically ill, adult patients. Objectives To summarize the available evidence on the diagnostic performance of clinical scores and laboratory tests for invasive candidiasis (IC) in nonneutropenic, adult critically ill patients. Methods A systematic review was performed to evaluate studies assessing the diagnostic performance for IC of clinical scores and/or laboratory tests vs. a reference standard or a reference definition in critically ill, nonneutropenic, adult patients in ICU. Results Clinical scores, despite the heterogeneity of study populations and IC prevalences, constantly showed a high negative predictive value (NPV) and a low positive predictive value (PPV) for the diagnosis of IC in the target population. Fungal antigen-based biomarkers (with most studies assessing serum beta-D-glucan) retained a high NPV similar to that of clinical scores, with a higher PPV, although the latter showed important heterogeneity across studies, possibly reflecting the targeted or untargeted use of these tests in patients with a consistent clinical picture and risk factors for IC. Conclusions Both clinical scores and laboratory tests showed high NPV for the diagnosis of IC in nonneutropenic critically ill patients. The PPV of laboratory tests varies significantly according to the baseline patients’ risk of IC. This qualitative synthesis will provide the FUNDICU panel with baseline evidence to be considered during the development of definitions of IC in critically ill, nonneutropenic adult patients in ICU.

10.1111/myc.13515http://hdl.handle.net/11383/2140709